[Interferon production in vitro]. 1987

R Kaise, and F Hirota, and K Sakamoto, and M Suminaga, and S Sato, and M Karibe, and K Nagai, and H Mugitani, and M Kako, and H Furue

Interferon production in vitro was induced by poly I: C and PHA in leukocytes obtained from patients with cancer, benign diseases and control subjects. The interferon response per lymphocyte was relatively constant in all groups. However, interferon production was slightly inhibited in patients receiving cancer chemotherapy. The peak response of interferon occurred at 48 hours after the initiation of the combined culture in each specimen. From our observations, it was suggested that interferon production in vitro seems to be useful marker for evaluation of effect of chemotherapy and or immunotherapy, and, furthermore, in the treatment of cancer patients with interferon inducers, there seems to be optimum BRM dose and optimum timing of administration.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009088 Mucoproteins Conjugated proteins in which mucopolysaccharides are combined with proteins. The mucopolysaccharide moiety is the predominant group with the protein making up only a small percentage of the total weight.
D009171 Mycolic Acids Long fatty acids found in the CELL WALLS of some ACTINOBACTERIA, including MYCOBACTERIUM TUBERCULOSIS. Mycolic Acid,Acid, Mycolic,Acids, Mycolic
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009615 Nocardia A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for humans and animals. Micropolyspora
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D011070 Poly I-C Interferon inducer consisting of a synthetic, mismatched double-stranded RNA. The polymer is made of one strand each of polyinosinic acid and polycytidylic acid. Poly(I-C),Poly(rI).Poly(rC),Polyinosinic-Polycytidylic Acid,Polyinosinic-Polycytidylic Acid (High MW),Polyriboinosinic-Polyribocytidylic Acid,Polyribose Inosin-Cytidil,Inosin-Cytidil, Polyribose,Poly I C,Polyinosinic Polycytidylic Acid,Polyriboinosinic Polyribocytidylic Acid,Polyribose Inosin Cytidil

Related Publications

R Kaise, and F Hirota, and K Sakamoto, and M Suminaga, and S Sato, and M Karibe, and K Nagai, and H Mugitani, and M Kako, and H Furue
November 1972, Applied microbiology,
R Kaise, and F Hirota, and K Sakamoto, and M Suminaga, and S Sato, and M Karibe, and K Nagai, and H Mugitani, and M Kako, and H Furue
January 1966, Annales medicinae experimentalis et biologiae Fenniae,
R Kaise, and F Hirota, and K Sakamoto, and M Suminaga, and S Sato, and M Karibe, and K Nagai, and H Mugitani, and M Kako, and H Furue
January 2008, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
R Kaise, and F Hirota, and K Sakamoto, and M Suminaga, and S Sato, and M Karibe, and K Nagai, and H Mugitani, and M Kako, and H Furue
January 1984, Voprosy virusologii,
R Kaise, and F Hirota, and K Sakamoto, and M Suminaga, and S Sato, and M Karibe, and K Nagai, and H Mugitani, and M Kako, and H Furue
February 1987, Arthritis and rheumatism,
R Kaise, and F Hirota, and K Sakamoto, and M Suminaga, and S Sato, and M Karibe, and K Nagai, and H Mugitani, and M Kako, and H Furue
January 1989, Bollettino dell'Istituto sieroterapico milanese,
R Kaise, and F Hirota, and K Sakamoto, and M Suminaga, and S Sato, and M Karibe, and K Nagai, and H Mugitani, and M Kako, and H Furue
January 1985, Journal of immunology (Baltimore, Md. : 1950),
R Kaise, and F Hirota, and K Sakamoto, and M Suminaga, and S Sato, and M Karibe, and K Nagai, and H Mugitani, and M Kako, and H Furue
November 1989, Laboratory animal science,
R Kaise, and F Hirota, and K Sakamoto, and M Suminaga, and S Sato, and M Karibe, and K Nagai, and H Mugitani, and M Kako, and H Furue
January 1963, The Journal of experimental medicine,
R Kaise, and F Hirota, and K Sakamoto, and M Suminaga, and S Sato, and M Karibe, and K Nagai, and H Mugitani, and M Kako, and H Furue
April 1970, Klinische Wochenschrift,
Copied contents to your clipboard!